Preferred Label : rozanolixizumab;
MeSH hyponym : UCB7665;
UNII : P7186074QC;
Origin ID : C000627812;
UMLS CUI : C4726717;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3594381/fr/rystiggo-rozanolixizumab-myasthenie
2025
false
false
false
France
drug therapy, combination
adult
treatment outcome
insurance, health, reimbursement
immunosuppressive agents
rozanolixizumab
generalised myasthenia gravis with anti-acetylcholine receptor antibody
Adult-onset myasthenia gravis
infusions, subcutaneous
evaluation of the transparency committee
myasthenia gravis
rozanolixizumab
---
https://ansm.sante.fr/tableau-acces-derogatoire/rozanolixizumab
2024
false
false
false
France
French
rozanolixizumab
drug information
---
https://www.has-sante.fr/jcms/p_3515653/fr/rystiggo-rozanolixizumab-myasthenie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
orphan drug production
rozanolixizumab
immunosuppressive agents
adult
myasthenia gravis, generalized
generalised myasthenia gravis with anti-acetylcholine receptor antibody
evaluation of the transparency committee
myasthenia gravis
rozanolixizumab
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rystiggo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rozanolixizumab
rozanolixizumab
drug approval
europe
orphan drug production
rozanolixizumab
immunosuppressive agents
immunosuppressive agents
adult
myasthenia gravis
Adult-onset myasthenia gravis
drug therapy, combination
infusions, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
fc receptor, neonatal
generalised myasthenia gravis with anti-acetylcholine receptor antibody
---